Healthcare
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced a new agreement with a major health insurer with a stronghold in Arizona, entered into through its strategic channel partnership with Amwell. This opportunity makes Dario's cardiometabolic solution available to the insurer's Administrative Services Only ("ASO") book of business, representing access to hundreds of thousands of covered lives.
About this update from Dariohealth Corp.
Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital health solution at scale to self-insured employers seeking measurable reductions in cardiometabolic risk and total cost of care via payer relationships NEW YORK, July 6, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced a new agreement with a major health insurer with a stronghold in Arizona, entered into through its strategic channel partnership with Amwell . This opportunity makes Dario's cardiometabolic solution available to the insurer's Administrative Services Only ("ASO") book of business, representing access to hundreds of thousands of covered lives. "This agreement demonstrates how our channel strategy is driving scalable, efficient access to large employer populations," said Erez Raphael, Dario's Chief Executive Officer. "By leveraging channel partner infrastructure and relationships, we can rapidly reach a high-value ASO population like this and embed Dario within the health plan ecosystem. This approach enables us to expand recurring revenue opportunities while delivering measurable clinical and economic outcomes for employers and reinforces a repeatable model for growth across our expanding channel partnerships." Dario's solution will be positioned as a differentiated offering within the insurer's ASO portfolio for employer clients seeking to address diabetes, hypertension and weight management through a unified, behaviorally-driven approach. Employers can adopt the solution based on their specific population needs and benefits strategy, with tailored deployments at scale. Dario uniquely delivers up to 5x return on investment ("ROI") to employers as demonstrated in a study funded by Sanofi and provides a clinically-grounded solution validated by more than 100 scientific studies, including peer reviewed journal publications and conference abstracts – which represents one of the largest bodies of published scientific evidence among all digital health companies. The savings seen by Dario clients are produced through fewer hospitalizations and improvements in key metrics, including systolic blood pressure, A1C and hyperglycemic events. Leveraging Amwell's market reach, Dario advances its capital-efficient growth model that lowers customer acquisition costs, accelerates sales cycles and supports scalable expansion across employer populations. Dario has access to over 116 million covered lives through its expanding channel partnership network.